• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人C反应蛋白的蛋白水解产生具有强大免疫调节活性的肽。

Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity.

作者信息

Robey F A, Ohura K, Futaki S, Fujii N, Yajima H, Goldman N, Jones K D, Wahl S

出版信息

J Biol Chem. 1987 May 25;262(15):7053-7.

PMID:3034878
Abstract

We have studied the ability of human C-reactive protein to modulate the immune response in vitro. Whereas native C-reactive protein did not induce phagocytic leukocytes to chemotax or to produce superoxide, treatment of purified C-reactive protein with human neutrophil-derived acid proteases produced substances with potent effects on leukocyte function. Close examination of the primary structure of human C-reactive protein revealed three regions evenly distributed throughout the protein each of which contain peptide sequences closely resembling the amino acid sequence of the immunomodulator peptide tuftsin, Thr-Lys-Pro-Arg. We have synthesized the three peptides which include Thr-Lys-Pro-Leu ([Leu4]tuftsin), Gly-Lys-Pro-Arg ([Gly1]tuftsin), and Thr-Lys-Pro-Gln ([Gln4]tuftsin) and assayed them for biological activity. The three synthetic peptides were found to stimulate phagocytic leukocytes to chemotax, produce superoxide, and induce mononuclear cells to produce interleukin 1 in vitro at concentrations similar to those concentrations required for tuftsin to induce these phenomena. These results support a potentially important role for C-reactive protein as a possible immunomodulator during inflammation.

摘要

我们研究了人C反应蛋白在体外调节免疫反应的能力。天然C反应蛋白不会诱导吞噬性白细胞发生趋化作用或产生超氧化物,而用人中性粒细胞衍生的酸性蛋白酶处理纯化的C反应蛋白会产生对白细胞功能有强效作用的物质。对人C反应蛋白一级结构的仔细研究揭示,在整个蛋白质中均匀分布着三个区域,每个区域都含有与免疫调节肽促吞噬素(苏氨酸-赖氨酸-脯氨酸-精氨酸)的氨基酸序列极为相似的肽序列。我们合成了三种肽,分别是苏氨酸-赖氨酸-脯氨酸-亮氨酸([亮氨酸4]促吞噬素)、甘氨酸-赖氨酸-脯氨酸-精氨酸([甘氨酸1]促吞噬素)和苏氨酸-赖氨酸-脯氨酸-谷氨酰胺([谷氨酰胺4]促吞噬素),并检测了它们的生物活性。结果发现,这三种合成肽在体外能刺激吞噬性白细胞发生趋化作用、产生超氧化物,并诱导单核细胞产生白细胞介素1,其所需浓度与促吞噬素诱导这些现象所需的浓度相似。这些结果支持了C反应蛋白在炎症过程中作为一种可能的免疫调节因子发挥潜在重要作用的观点。

相似文献

1
Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity.人C反应蛋白的蛋白水解产生具有强大免疫调节活性的肽。
J Biol Chem. 1987 May 25;262(15):7053-7.
2
Competition between tuftsin and HBV S-protein sequences.促吞噬素与乙肝病毒表面蛋白序列之间的竞争
Int J Pept Protein Res. 1990 May;35(5):428-33. doi: 10.1111/j.1399-3011.1990.tb00069.x.
3
Synthetic peptides from C-reactive protein containing tuftsin-related sequences.来自含有促吞噬素相关序列的C反应蛋白的合成肽。
Peptides. 1986 Nov-Dec;7(6):961-8. doi: 10.1016/0196-9781(86)90121-x.
4
The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.病毒衣壳蛋白的一些促吞噬肽及促吞噬肽抑制剂样片段的镇痛活性。
Pol J Pharmacol. 1993 May-Jun;45(3):269-79.
5
Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.吞噬细胞增强因子及其部分序列对豚鼠动脉血压的影响。
Arch Immunol Ther Exp (Warsz). 1991;39(1-2):147-52.
6
[Stimulation of oxygen metabolism in human blood phagocytes as affected by tuftsin-like peptides derived from the C-reactive protein molecule].[C反应蛋白分子衍生的类tuftsin肽对人血吞噬细胞氧代谢的刺激作用]
Biull Eksp Biol Med. 1993 Jan;115(1):55-6.
7
Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.P物质1-4四肽及一些促吞噬素类似物的抗伤害感受作用。
Pol J Pharmacol Pharm. 1990 Jul-Aug;42(4):393-401.
8
New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.新型合成及天然与促吞噬肽相关的化合物及其吞噬刺激活性评估。
Ann N Y Acad Sci. 1983;419:23-34. doi: 10.1111/j.1749-6632.1983.tb37088.x.
9
Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.吞噬细胞调理素与HIV-1、HIV-2包膜蛋白序列之间的竞争。
Arch Immunol Ther Exp (Warsz). 1991;39(5-6):469-78.
10
Synthesis and biological activity of [L-3,4-dehydroproline3]-tuftsin.[L-3,4-脱氢脯氨酸3]-促吞噬肽的合成与生物活性
Peptides. 1984 May-Jun;5(3):489-94. doi: 10.1016/0196-9781(84)90075-5.

引用本文的文献

1
Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.通过 SWATH 质谱和定量靶向绝对蛋白质组学鉴定胶质母细胞瘤中的血液生物标志物。
PLoS One. 2018 Mar 7;13(3):e0193799. doi: 10.1371/journal.pone.0193799. eCollection 2018.
2
Microglia/macrophages promote glioma progression.小胶质细胞/巨噬细胞促进神经胶质瘤进展。
Glia. 2011 Mar;59(3):472-85. doi: 10.1002/glia.21117. Epub 2010 Dec 29.
3
The connection between C-reactive protein and atherosclerosis.C反应蛋白与动脉粥样硬化之间的联系。
Ann Med. 2008;40(2):110-20. doi: 10.1080/07853890701749225.
4
ITF1697, a stable Lys-Pro-containing peptide, inhibits weibel-palade body exocytosis induced by ischemia/reperfusion and pressure elevation.ITF1697是一种稳定的含赖氨酸-脯氨酸的肽,可抑制缺血/再灌注和压力升高诱导的魏尔-帕拉德小体胞吐作用。
Mol Med. 2007 Nov-Dec;13(11-12):615-24. doi: 10.2119/2007-00079.Bertuglia.
5
The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates.漏出液和渗出液中的急性期蛋白血清淀粉样蛋白A和C反应蛋白。
Mediators Inflamm. 2006;2006(1):47297. doi: 10.1155/MI/2006/47297.
6
Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.通过C反应蛋白及源自C反应蛋白的肽促使L-选择素脱落,从而预防体外中性粒细胞与内皮细胞的黏附。
J Clin Invest. 1997 Aug 1;100(3):522-9. doi: 10.1172/JCI119561.
7
Do high levels of C-reactive protein in Tanzanian children indicate malaria morbidity.坦桑尼亚儿童体内高水平的C反应蛋白是否表明患有疟疾?
Clin Diagn Lab Immunol. 1994 Jul;1(4):437-44. doi: 10.1128/cdli.1.4.437-444.1994.
8
A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein.一种解释人类C反应蛋白天然形式和改变形式明显不同活性的假说。
Immunol Res. 1993;12(1):37-47. doi: 10.1007/BF02918367.
9
Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models.C反应蛋白合成肽在临床前肿瘤模型中的治疗效果。
Cancer Immunol Immunother. 1993;36(3):171-6. doi: 10.1007/BF01741088.
10
Why measure C reactive protein?为什么要检测C反应蛋白?
Gut. 1994 Jan;35(1):5-7. doi: 10.1136/gut.35.1.5.